CVS Caremark (CVS) Tops Q3 EPS by 3c; Adjusts FY11 EPS Below Views
Tweet
Share
E-mailGet Alerts CVS Hot Sheet
Price: $87.37 -1.65%
Revenue Growth %: +1.3%
Financial Fact:
Gross profit: 7.49B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Revenue Growth %: +1.3%
Financial Fact:
Gross profit: 7.49B
Today's EPS Names:
ALZN, ASPU, OCCI, More
Join SI Premium – FREE
CVS Caremark (NYSE: CVS) reported Q3 EPS of $0.70, $0.03 better than the analyst estimate of $0.67. Revenue for the quarter came in at $26.7 billion versus the consensus estimate of $26.76 billion.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
CVS Caremark sees FY2011 EPS of $2.57-$2.61, versus the consensus of $2.78.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- HP Inc. projects mid-single-digit PC market decline in 2027
- CVS Health Launches National "Wear Your HeART" Bandage Art Contest
- CVS Health Redevelops Soccer Pitch Alongside Seattle Reign FC and the RAVE Foundation
Create E-mail Alert Related Categories
Earnings, Guidance, Hot GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
